SEC Form 4 · accession 0001209191-15-063715

LEMAITRE VASCULAR INC · LMAT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Jul 31, 2015

Accepted (ET)

Aug 4, 2015 · 5:08 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001158895

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jul 31, 2015	M	5,319	$11.78	A	56,061	D
Common Stock^F2	Jul 31, 2015	S	5,319	$14.2631	D	50,742	D
Common Stock^F1	Aug 3, 2015	M	2,499	$11.78	A	53,241	D
Common Stock^F3	Aug 3, 2015	S	2,499	$14.2805	D	50,742	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$11.78	Jul 31, 2015	M	5,319	D	Dec 22, 2005	Dec 22, 2015	Common Stock	5,319	94,681	D
Stock Option (Right to Buy)^F4	$11.78	Aug 3, 2015	M	2,499	D	Dec 22, 2005	Dec 22, 2015	Common Stock	2,499	92,182	D

F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $14.25 to $14.29. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $14.25 to $14.35. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4This option is fully vested and exercisable.